Keratinocytes and remnant of keratinocytes in nodules, abscesses, and sinus tracts are radically removed in surgical treatment of hidradenitis suppurativa. 1 We are now using methylene blue in carbon dioxide laser surgery for patients with moderate to severe hidradenitis lesions (Hurley stage II-III). Methylene blue stains active inflammatory nodules and sinus tracts. We use a modified methylene blue staining technique by the addition of 2% gel of methylcellulose polymers to the dye. The resulting blue gel is easier to handle than a liquid, and is injected or probed into sinus tracts with either a syringe or a cotton swab, resulting in limited dye spillage and a clean operating field. Major tracts are normally easy to probe without staining. However, tracts with hidden orifices and minor branches of epithelialized tracts with diameters too small diameter to probe can be revealed using methylene blue. Figure 1 shows instillation procedure in a sinus tract and uptake of methylene blue gel in lesional skin tissue.
Discussion
Several surgical treatment methods for hidradenitis exist, hereunder, deroofing, excision, carbon dioxide laser vaporization, and electrosurgery. Leaving epi-thelialized tissue untreated may be one cause of recurrent disease. Communicating tracts must be found and explored intraoperatively for curative excision or deroofing. The common method of exploring sinus tracts is using a blunt probe. Electrosurgery and carbon dioxide laser deroofing is often combined with probing. 2, 3 Another method to identify sinus tracts is to use dye intraoperatively.
Methylene blue is a vital stain taken up by actively absorbing tissues, among them stratified epithelium. It is commonly used in head, neck, and parathyroid surgery, for sentinel lymph node detection, testing of the integrity of gastrointestinal anastomosis as well as in fistuli and sinus detection in bladder, bowel, anal, and pilonidal sinus surgery.
When comparing primary open, primary midline closed, and marsupialization surgery of pilonidal sinus disease, methylene blue was found to be the most potent factor, leading to the largest reduction in recurrence rate. 4 Use of methylene blue is recently described in wide excision surgery of hidradenitis, but to our knowledge, there are no reports of methylene blue use in hidradenitis laser surgery. 5 Since 1997, we have used scanner-assisted carbon dioxide laser with recurrent symptomatic hidradenitis lesions with the technique of carbon dioxide laser vaporization of nodules and sinus tracts. We consider methylene blue to be a tissuesaving adjuvant, as the outlining of affected structures warrants less radical vaporization of tissue in affected areas. For the patient, a smaller postoperative wound results in faster healing, less scarring, and reduced risk of skin contractures.
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How I Do It: Treatment of Plantar Calluses and Corns With an Erbium-Doped Yttrium Aluminum

Garnet Laser
The treatment options of calluses and corns include cryosurgery, chemical agents, electrosurgery, and scalpel removal; however, these present different limitations and side effects. 1 The failure of conventional treatments may necessitate surgical intervention.
The erbium-doped yttrium aluminium garnet laser (Er:YAG) ablates tissue with surgical precision creating minimal collateral thermal damage with the wavelength of 2,940 nm, which is strongly absorbed by liquid water in the tissue. 2 Therefore, the authors evaluated the efficacy and safety of Er:YAG in treating calluses and corns as a minimally invasive alternative.
Materials and Methods
This study was conducted with 70 patients admitted to the Department of Dermatology, Istanbul Medipol University, Turkey, with plantar callus between 2012 and 2014. After approval by the ethics committee, 102 lesions were retrospectively evaluated. Patients provided written informed consent. For patients aged below 18, informed consent was obtained from a parent or legal guardian. Patients who had a serious systemic disease or were pregnant or potentially pregnant and those with a history of epilepsy, preexisting melanoma, or hypertrophic scar formation due to traumatic process predisposition to hemorrhage or immunological disorder were excluded from the study.
For the treatment of calluses, the Er:YAG laser (Dynamis SP II; Fotona, Ljubljana, Slovenia) was used. Before treatment, local anesthesia was administered around the callus with 3 to 4 radially distributed points of injection. Scalpel debulking was not performed. The laser was performed with a spot size of 2 to 4 mm at a frequency between 1.2 and 1.6 Hz using a mode between basic and turbo 6 at a fluence of 20.0 to 40.0 J/cm 2 . The treatment sessions were continued at 1-month intervals until complete or partial healing. The laser-treated areas were covered with topical cream to keep them moist and lubricated, and bandaged for 2 to 3 days. Two weeks after each session, patients returned to the clinic for the assessment and documentation of wound healing. Side effects including posttreatment pain,
